These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 33504234)

  • 1. Asthma medication in athletes: a qualitative investigation of adherence, avoidance and misuse in competitive sport.
    Allen H; Price OJ; Hull JH; Backhouse SH
    J Asthma; 2022 Apr; 59(4):811-822. PubMed ID: 33504234
    [No Abstract]   [Full Text] [Related]  

  • 2. Between medical treatment and performance enhancement: an investigation of how elite athletes experience Therapeutic Use Exemptions.
    Overbye M; Wagner U
    Int J Drug Policy; 2013 Nov; 24(6):579-88. PubMed ID: 23582632
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Barriers and enablers in doping, anti-doping, and clean sport: A qualitative meta-synthesis informed by the theoretical domains framework and COM-B model.
    Williams TL; Patterson LB; Heyes AR; Staff HR; Boardley ID; Petróczi A; Backhouse SH
    Psychol Sport Exerc; 2024 May; 72():102608. PubMed ID: 38360079
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Anti-doping Policy, Therapeutic Use Exemption and Medication Use in Athletes with Asthma: A Narrative Review and Critical Appraisal of Current Regulations.
    Allen H; Backhouse SH; Hull JH; Price OJ
    Sports Med; 2019 May; 49(5):659-668. PubMed ID: 30887312
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The use of prohibited substances for therapeutic reasons in athletes affected by endocrine diseases and disorders: the therapeutic use exemption (TUE) in clinical endocrinology.
    Di Luigi L; Pigozzi F; Sgrò P; Frati L; Di Gianfrancesco A; Cappa M
    J Endocrinol Invest; 2020 May; 43(5):563-573. PubMed ID: 31734891
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sports nutritionists' perspectives on enablers and barriers to nutritional adherence in high performance sport: A qualitative analysis informed by the COM-B model and theoretical domains framework.
    Bentley MR; Mitchell N; Sutton L; Backhouse SH
    J Sports Sci; 2019 Sep; 37(18):2075-2085. PubMed ID: 31124393
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Doping Prevalence in Competitive Sport: Evidence Synthesis with "Best Practice" Recommendations and Reporting Guidelines from the WADA Working Group on Doping Prevalence.
    Gleaves J; Petróczi A; Folkerts D; de Hon O; Macedo E; Saugy M; Cruyff M
    Sports Med; 2021 Sep; 51(9):1909-1934. PubMed ID: 33900578
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Doping in sport: a review of elite athletes' attitudes, beliefs, and knowledge.
    Morente-Sánchez J; Zabala M
    Sports Med; 2013 Jun; 43(6):395-411. PubMed ID: 23532595
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The asthmatic athlete: inhaled Beta-2 agonists, sport performance, and doping.
    McKenzie DC; Fitch KD
    Clin J Sport Med; 2011 Jan; 21(1):46-50. PubMed ID: 21200170
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Medication, athletes and doping regulations].
    Hartgens F
    Ned Tijdschr Geneeskd; 2008 Aug; 152(33):1844-8. PubMed ID: 18783164
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Doping control from a global and national perspective.
    Fraser AD
    Ther Drug Monit; 2004 Apr; 26(2):171-4. PubMed ID: 15228160
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Attitudes and doping: a structural equation analysis of the relationship between athletes' attitudes, sport orientation and doping behaviour.
    Petróczi A
    Subst Abuse Treat Prev Policy; 2007 Nov; 2():34. PubMed ID: 17996097
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Is there a danger for myopia in anti-doping education? Comparative analysis of substance use and misuse in Olympic racket sports calls for a broader approach.
    Kondric M; Sekulic D; Petroczi A; Ostojic L; Rodek J; Ostojic Z
    Subst Abuse Treat Prev Policy; 2011 Oct; 6():27. PubMed ID: 21988896
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Self-determined motivation in sport predicts anti-doping motivation and intention: a perspective from the trans-contextual model.
    Chan DK; Dimmock JA; Donovan RJ; Hardcastle S; Lentillon-Kaestner V; Hagger MS
    J Sci Med Sport; 2015 May; 18(3):315-22. PubMed ID: 24793786
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Psychological and social correlates of doping attitudes among Italian athletes.
    Zucchetti G; Candela F; Villosio C
    Int J Drug Policy; 2015 Feb; 26(2):162-8. PubMed ID: 25168080
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A conceptual framework for achieving performance enhancing drug compliance in sport.
    Donovan RJ; Egger G; Kapernick V; Mendoza J
    Sports Med; 2002; 32(4):269-84. PubMed ID: 11929355
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A Moral Foundation for Anti-Doping: How Far Have We Progressed? Where Are the Limits?
    Murray TH
    Med Sport Sci; 2017; 62():186-193. PubMed ID: 28571014
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Impact of changes in anti-doping regulations (WADA Guidelines) on asthma care in athletes.
    Couto M; Horta L; Delgado L; Capão-Filipe M; Moreira A
    Clin J Sport Med; 2013 Jan; 23(1):74-6. PubMed ID: 22948449
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Australian athletes' knowledge of the WADA Prohibited Substances List and performance enhancing substances.
    Orr R; Grassmayr M; Macniven R; Grunseit A; Halaki M; Bauman A
    Int J Drug Policy; 2018 Jun; 56():40-45. PubMed ID: 29550541
    [TBL] [Abstract][Full Text] [Related]  

  • 20. "Doing What Is Right and Doing It Right": A Mapping Review of Athletes' Perception of Anti-Doping Legitimacy.
    Woolway T; Lazuras L; Barkoukis V; Petróczi A
    Int J Drug Policy; 2020 Oct; 84():102865. PubMed ID: 32738700
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.